World's Best Scientists 2026 revealed!
Raymund R. Razonable

Raymund R. Razonable

D-Index & Metrics

Microbiology

D-Index
80
Citations
20783
World Ranking
1175
National Ranking
529

Overview

Raymund R. Razonable is affiliated with the Mayo Clinic in the United States and has contributed extensively to medical research, with a focus primarily on infectious diseases. Their research spans various interconnected fields, including epidemiology, neurology, surgery, and public health, environmental and occupational health.

The scientist has published numerous papers in several notable venues. Frequent publication outlets include Open Forum Infectious Diseases, Transplant Infectious Disease, Mayo Clinic Proceedings, American Journal of Transplantation, and bioRxiv (Cold Spring Harbor Laboratory).

Research topics covered by Raymund R. Razonable include:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Cytomegalovirus and herpesvirus research
  • Long-Term Effects of COVID-19
  • Herpesvirus Infections and Treatments
  • Fungal Infections and Studies
  • Antifungal resistance and susceptibility

Coauthors frequently collaborating with this scientist are:

  • Ravindra Ganesh
  • Zachary A. Yetmar
  • John C. O'Horo
  • Sidna M. Tulledge-Scheitel
  • Paschalis Vergidis

Major papers published by Raymund R. Razonable include:

  • Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19, 2021, EClinicalMedicine
  • Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors, 2020, JAMA
  • Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis, 2020, eLife
  • Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019, 2021, The Journal of Infectious Diseases
  • Treatment Considerations for COVID-19, 2020, Mayo Clinic Proceedings

Their work contributes heavily to the understanding of viral infections, especially those related to cytomegalovirus and herpesvirus, alongside a significant emphasis on clinical research concerning COVID-19. This includes treatment strategies and study of outcomes in high-risk patient populations.

Raymund R. Razonable's research profile reflects a broad and interdisciplinary approach, integrating clinical practice and epidemiological insights to address pressing infectious diseases challenges. Their contributions support ongoing developments in infection management, antiviral therapy, and public health strategies related to emerging and persistent viral threats.

Best Publications

  • Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.

    Per Ljungman;Per Ljungman;Michael Boeckh;Michael Boeckh;Hans H Hirsch;Filip Josephson

  • Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.

    Raymund R. Razonable;Atul Humar;Atul Humar

  • Cytomegalovirus in Solid Organ Transplantation

    R. R. Razonable;A. Humar

  • Chromosomally integrated human herpesvirus 6: questions and answers

    Philip E. Pellett;Dharam V. Ablashi;Peter F. Ambros;Henri Agut

  • Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: A multicentre cohort study

    Deepali Kumar;Marian G. Michaels;Michele I. Morris;Michael Green

  • Cytomegalovirus infections in solid organ transplantation: a review.

    Poornima Ramanan;Raymund R Razonable

  • Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

    Supha K. Arthurs;Albert J. Eid;Rachel A. Pedersen;Walter K. Kremers

  • Serious infections caused by methicillin-resistant Staphylococcus aureus.

    Helen Boucher;Loren G. Miller;Raymund R. Razonable

  • Allograft Rejection Predicts the Occurrence of Late-Onset Cytomegalovirus (CMV) Disease among CMV-Mismatched Solid Organ Transplant Patients Receiving Prophylaxis with Oral Ganciclovir

    Raymund R. Razonable;Antonio Rivero;Aurelio Rodriguez;Jennie Wilson

  • Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus

    Raymund R. Razonable

  • Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.

    Kelly W. Burak;Walter K. Kremers;Kenneth P. Batts;Russell H. Wiesner

  • Parvovirus B19 Infection after Transplantation: A Review of 98 Cases

    Albert J. Eid;Robert A. Brown;Robin Patel;Raymund R. Razonable

  • Clinical Utility of Viral Load in Management of Cytomegalovirus Infection after Solid Organ Transplantation

    Raymund R. Razonable;Randall T. Hayden

  • New developments in the management of cytomegalovirus infection after solid organ transplantation.

    Albert J. Eid;Raymund R. Razonable

  • Cytomegalovirus infection after liver transplantation: Current concepts and challenges

    Raymund Rabe Razonable

  • Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients.

    Raymund R. Razonable;Carlos V. Paya;Thomas F. Smith

  • Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes.

    Albert J Eid;Supha K Arthurs;Paul J Deziel;Mark P Wilhelm

  • The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease.

    Raymund R. Razonable;Robert A. Brown;Jennie Wilson;Cynthia Groettum

  • Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.

    Roy F. Chemaly;Sunwen Chou;Hermann Einsele;Paul Griffiths

  • Management of CMV infection and disease in transplant patients. 27-29 February 2004.

    Raymund R Razonable;Vincent C Emery

  • Clinical Utility of Cytomegalovirus (CMV) Serology Testing in High‐risk CMV D+/R− Transplant Recipients

    Atul Humar;Tony Mazzulli;George Moussa;Raymund R. Razonable

Frequent Co-Authors

Carlos V. Paya
Carlos V. Paya Eli Lilly (United States)
Nina Singh
Nina Singh University of Pittsburgh
Marilyn M. Wagener
Marilyn M. Wagener University of Pittsburgh
Ajit P. Limaye
Ajit P. Limaye University of Washington
Thomas F. Smith
Thomas F. Smith Mayo Clinic
Robin Patel
Robin Patel Mayo Clinic
Gregory J. Gores
Gregory J. Gores Mayo Clinic
Andrew D. Badley
Andrew D. Badley Mayo Clinic
Shahid Husain
Shahid Husain University Health Network

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology in the USA opens doors to diverse career pathways, many of which can be enhanced through specialized online degrees and certifications. For those interested in healthcare roles, becoming a functional nurse practitioner offers a way to apply scientific knowledge directly to patient care, often requiring advanced online education.

Additionally, careers in medical coding and health information management are growing fields, especially for microbiology graduates who wish to work behind the scenes in healthcare. Earning a professional coder certification can lead to roles focused on accuracy and compliance, supporting clinical operations.

For individuals with unique backgrounds, including those looking for online degrees for felons, many institutions offer accessible and reputable programs. These pathways help break barriers and support career advancement in scientific and healthcare fields.

Moreover, fields like child life specialization may appeal to those interested in combining microbiology knowledge with supportive healthcare roles. Pursuing a ccls certification is one such step to build expertise in this rewarding area.

Best Scientists Citing Raymund R. Razonable

Trending Scientists